Investment Summary |
|
|---|---|
| Date | 2013-12-13 |
| Target | Cheniere Energy |
| Sector | Energy Services and Equipment |
| Sellers(s) |
Scorpion Capital Partners
The Blackstone Group |
| Deal Type | IPO |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 1995 |
| PE ASSETS | 120M USD |
| Size | Small |
| Type | Sector Agnostic |
Scorpion Capital Partners LP is a private equity firm that partners with management to invest in smaller middle-market companies. Scorpion looks to make equity or equity like investments of $5 to $10 million in businesses with $10 to $100 million of revenue and EBITDA of $4 to $25 million. The Firm will consider both control and minority investment to support growth capital needs, recapitlizations, divestitures, take privates, and family successions. Scorpion has no industry focus, however the Firm will not invest in real estate, gaming, tobacco, biotechnology, software development, as well as start-up and early stage ventures. Scorpion Capital Partners was originally established in 1995 and is based in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 8 |
| Sector (Energy Services and Equipment) | 1 of 1 |
| Type (IPO) | 1 of 1 |
| State (Texas) | 2 of 2 |
| Country (United States) | 5 of 8 |
| Year (2013) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-02-04 |
Velocity Express
Stafford, Texas, United States Velocity Express Corp. is a provider of time critical supply chain solutions. Velocity and has one of the largest nationwide networks and provides a national footprint for customers desiring same day delivery and logistics services throughout the United States. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-08-22 |
3D Medical Manufacturing
Riviera Beach, Florida, United States 3D Medical Manufacturing is a manufacturer of critical high precision medical device implants, cutting tools, instruments, and electro-mechanical assemblies. Specializing in full service fabrication from materials of Titanium, Stainless Steel, PEEK, precious metal, Aluminum, and plastic that demand close tolerances and superior cosmetic finishing. |
Sell | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1987 |
| PE ASSETS | 131.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
The Blackstone Group is a global alternative investment management firm. The Firm's investment activities span real estate, secondary investments, hedge funds, credit, infrastructure, and private equity. Blackstone's private equity group targets opportunities globally including buyout acquisitions of established companies, development projects, growth equity financings, and industry consolidations. Sectors of interest include automotive, healthcare, chemicals, industrial, commercial property, lodging, communications, media/publishing, consumer & retail, packaging, consumer products, pharmaceuticals, energy, technology, entertainment, telecommunications, financial services, theme parks, food & beverage, and transportation. Blackstone's private equity real estate group looks for opportunities across North/South America, Asia, Australia/New Zealand, and Europe. The real estate group will consider both equity and debt investments. Areas of interest include healthcare, hotel, industrial, office, residential, and retail. The Blackstone Group was formed in 1987 and is based in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 82 of 167 |
| Sector (Energy Services and Equipment) | 3 of 5 |
| Type (IPO) | 27 of 38 |
| State (Texas) | 7 of 15 |
| Country (United States) | 56 of 101 |
| Year (2013) | 12 of 13 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-12-12 |
Hilton
McLean, Virginia, United States Hilton is a global hospitality company, spanning the lodging sector from luxury and full-service hotels and resorts to extended-stay suites and focused-service hotels. Hilton was formed in 1919 and is based in McLean, Virginia. Hilton was founded in 1919 and is based in McLean, Virginia. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-12-19 |
Emcure Pharmaceuticals
Pune, India Emcure Pharmaceuticals is a mid-sized pharmaceutical business. The company's activities include research & development; manufacturing of APIs, branded formulations and biotech products; and marketing of these products in India and international markets |
Sell | - |
